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Objectives
In order to suppress HIV and delay evolution to AIDS,
antigen-loaded DC might be useful to boost and broaden
HIV-1-specific T-cell responses, which are dysfunctional
in HIV infection.
Methods
DC (from 15 treatment-naïve and 15 HAART-treated HIV-
1-infected patients) were electroporated with codon-opti-
mized mRNA encoding consensus HxB-2 Gag. These DC
were co-cultured for 1 week with autologous peripheral
blood leucocytes. Expansion of specific T-cells was meas-
ured by ELISPOT, using a pool of overlapping peptides,
spanning HxB-2 Gag.
Results
Expansion of specific T cells producing IFN-γ, IL-2 and
perforin was seen. Comparing the response between 12
treated and 12 naïve patients, matched in absolute CD4+
T-cell count, showed that the response was higher in
treated subjects for IFN-γ and IL-2 but not for perforin.
HxB-2 peptides induced IFN-γ in CD4+ and CD8+ T-cell
subsets purified following coculture, IL-2 was only
secreted by CD4+ T-cells and perforin was dominantly
secreted by CD8+ T-cells. Remarkably, the perforin
response in naïve persons was negatively correlated with
the absolute CD4+ and CD8+ T-cell count. The nadir
CD4+ T-cell count in treated subjects was positively corre-
lated with the IL-2 response and negatively correlated
with the perforin response.
Conclusion
HxB-2 gag mRNA-transfected DC from treated and naïve
subjects have the capacity to induce secondary T-cell
responses. These results of this and another study, where
we showed that T-cells from naïve HIV-infected subjects
can be triggered by DC electroporated with autologous
gag mRNA (Blood 2006;107:1818-27), open the perspec-
tive for a DC immunotherapy of HIV disease.
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